Podoplanin
Sign in to saveAlso known as Aggrus, hT1alpha-2, hT1alpha-1, glycoprotein 36, PA2.26 antigen, T1-alpha, PDPN protein, human
PDPN, i.e., podoplanin, is a small glycoprotein located on the surface membranes of various cell types. While termed PDPN in humans, it is often named: a) OTS-8, gp38, aggrus, antigen PA2.26, or RANDAM-2 (i.e., retinoic acid-induced neuronal differentiated-associated molecule-2) in mice; b) T1α protein or E11 antigen in rats; c) aggrus or gp40 in canines; and d) aggrus in hamsters and cows. Human PDPN is encoded by the PDPN gene located on the "p", i.e., short, arm of chromosome 1, region 3, band 1 (location notated as 1p36.21; see Gene nomenclature). This gene directs the formation of PDPN me
Protein · UniProt
Podoplanin
- Gene
- PDPN
- Organism
- Homo sapiens (Human)
- Length
- 162 aa
- Molecular mass
- 16,698 Da
- Evidence
- 1: Evidence at protein level
Mediates effects on cell migration and adhesion through its different partners. During development plays a role in blood and lymphatic vessels separation by binding CLEC1B, triggering CLEC1B activation in platelets and leading to platelet activation and/or aggregation (PubMed:14522983, PubMed:15231832, PubMed:17222411, PubMed:17616532, PubMed:18215137). Interaction with CD9, on the contrary, attenuates platelet aggregation induced by PDPN (PubMed:18541721). Through MSN or EZR interaction promotes epithelial-mesenchymal transition (EMT) leading to ERZ phosphorylation and triggering RHOA acti…
Swiss-Prot (reviewed) · via UniProt
Clinical Trials
19 registered- NARECRUITINGProtocol Active Surveillance Small Renal Masses (SRMs)IRCCS San Raffaele · NCT03804320
- NAUNKNOWNSubmucosal Saline Injection Followed by Endoscopic UltrasoundSun Yat-sen University · NCT06022978
- PHASE2TERMINATEDInvestigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal FunctionFox Chase Cancer Center · NCT02633540
- PHASE1WITHDRAWNOncolytic Adenovirus-Mediated Gene Therapy for Lung CancerBenjamin Movsas, M.D. · NCT03029871
- PHASE2COMPLETEDRadiation Therapy Plus Amifostine in Treating Patients With Primary Prostate CancerUniversity of Arizona · NCT00003307
- NANOT_YET_RECRUITINGSLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell CarcinomaFujian Cancer Hospital · NCT06979986
Wikidata facts
- Instance of
- protein
Show 3 more facts
- cell component
- filopodium
- found in taxon
- Homo sapiens
- exact match
- purl.uniprot.org/uniprot/Q86YL7
via Wikidata · CC0
~34 min read
Encyclopedic overview
21 sectionsContents
- Tissues distribution
- Structure
- Activation of CLEC-2
- Function and clinical significance
- Platelet activation
- Platelet formation
- Hair follicle growth
- Development of blood vessels, lymphatic vessels, and the heart
- Development of the lung
- Kidney function
- Allergic contact dermatitis
- Regeneration of the liver after hepatectomy
- Repair myocardial infarction
- Atherosclerosis
- Ischemia/reperfusion tissue damage
- Deep vein thrombosis
- Cancer-associated venous thromboembolisms
- Cancer
- Inhibitors
- References
- External links
PDPN, i.e., podoplanin, is a small glycoprotein located on the surface membranes of various cell types. While termed PDPN in humans, it is often named: a) OTS-8, gp38, aggrus, antigen PA2.26, or RANDAM-2 (i.e., retinoic acid-induced neuronal differentiated-associated molecule-2) in mice; b) T1α protein or E11 antigen in rats; c) aggrus or gp40 in canines; and d) aggrus in hamsters and cows. Human PDPN is encoded by the PDPN gene located on the "p", i.e., short, arm of chromosome 1, region 3, band 1 (location notated as 1p36.21; see Gene nomenclature). This gene directs the formation of PDPN messenger RNA (i.e., mRNA) which in turn directs formation of the PDPN glycoprotein. Here, the term PDPN is used for the non-human as well as human glycoprotein, PDPN is used for the human gene, and Pdpn is used for the animal gene.
Studies to date have suggested that PDPN acts to promote or inhibit a wide range of physiological and pathological reactions in rodents and, in a few studies, humans. However, almost all of these studies are preliminary and require far larger follow-up studies to determine if regulating PDPN levels could be used in humans to treat the various PDPN-regulated functional responses and PDPD-induced disorders. Indeed, studies have not yet determined if the promotion or inhibition of PDPN actions can be used safely in humans.
Excerpted from Wikipedia’s “Podoplanin” article, available under the CC BY-SA 4.0 licence.